Cargando…
Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation
Health economic analyses are essential for health services research, providing decision-makers and payers with evidence about the value of interventions relative to their opportunity cost. However, many health economic approaches are still limited, especially regarding the primary prevention of card...
Autores principales: | Ademi, Zanfina, Morton, Jedidiah I., Liew, Danny, Nicholls, Stephen J., Zoungas, Sophia, Ference, Brian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550676/ https://www.ncbi.nlm.nih.gov/pubmed/36006601 http://dx.doi.org/10.1007/s40273-022-01183-1 |
Ejemplares similares
-
Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022–2031
por: Abushanab, Dina, et al.
Publicado: (2023) -
Projected New-Onset Cardiovascular Disease by Socioeconomic Group in Australia
por: Hastings, Kaitlyn, et al.
Publicado: (2022) -
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
por: Morton, Jedidiah I., et al.
Publicado: (2022) -
Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective
por: Ademi, Zanfina, et al.
Publicado: (2016) -
Productivity-Adjusted Life-Years: A New Metric for Quantifying Disease Burden
por: Ademi, Zanfina, et al.
Publicado: (2021)